Stability study of Fluconazole capsules with Bracketing Design

International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines provide guidance for stability monitoring of medicines which Food and Drug Administration (FDA) and European Medicines Agency (EMA) refer to. A full stability study design is descri...

Full description

Saved in:
Bibliographic Details
Main Authors: Aleksandra Chakarjanevska¹, Marika Bogoevska Nikolovska, Mirsada Dervisevic Andonova, Irena Slaveska Spirevska, Marija Karapandzova, Suzana Trajkovic Jolevska, Jasmina Tonic Ribarska
Format: Article
Language:English
Published: University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy and Macedonian Pharmaceutical Association 2024-12-01
Series:Makedonsko Farmacevtski Bilten
Subjects:
Online Access:https://bulletin.mfd.org.mk/volumes/Volume%2069_1/69_1_007.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines provide guidance for stability monitoring of medicines which Food and Drug Administration (FDA) and European Medicines Agency (EMA) refer to. A full stability study design is described as a model in which samples under the influence of appropriate factors are tested at all-time points. Bracketing and matrixing stability study designs represent reduced designs that may be a suitable alternative to a full stability design. Bracketing design refers to the stability such that only samples on the extremes of certain design are tested at all-time points as in a full design, whereas the stability of the intermediate levels is represented by the stability of the tested extremes, which reduces costs and time analysis. The design assumes that the stability of any intermediate levels is represented by the stability of the extremes tested. Bracketing design of four different dosage strengths of Fluconazole hard capsules is included in this research. The extreme strengths were chosen and parameters average mass of capsule contents, disintegration, dissolution, assay of active and related substances, according to shelf-life specification were tested in accelerated and long-term stability conditions. Based on the obtained results, the stability of any intermediate levels is confirmed by the stability of the tested extremes and show that this reduced design is suitable.
ISSN:1857-8969